Last reviewed · How we verify
Low-concentration carbohydrate — Competitive Intelligence Brief
marketed
Diabetes
Small molecule
Live · refreshed every 30 min
Target snapshot
Low-concentration carbohydrate (Low-concentration carbohydrate) — Ain Shams University. Low-concentration carbohydrate formulations reduce glycemic load and postprandial blood glucose spikes by slowing carbohydrate absorption and digestion.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Low-concentration carbohydrate TARGET | Low-concentration carbohydrate | Ain Shams University | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Low-concentration carbohydrate CI watch — RSS
- Low-concentration carbohydrate CI watch — Atom
- Low-concentration carbohydrate CI watch — JSON
- Low-concentration carbohydrate alone — RSS
Cite this brief
Drug Landscape (2026). Low-concentration carbohydrate — Competitive Intelligence Brief. https://druglandscape.com/ci/low-concentration-carbohydrate. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing